COUNTDOWN TO THE EXTENDED DEADLINE
WELCOME TO THE MM+M AWARDS
The first entry deadline has been set at April 12, with each entry costing $495. Entries submitted before the final deadline of April 26 will cost $795. Click here to access the entry kit.
This year’s winners will be revealed at the annual gala event scheduled for October 10 in New York City. MM+M will unveil the Awards shortlist in July.
New categories for 2024 include: Use of Podcasting and Use of Artificial Intelligence (AI).
For a category to be judged, it must have at least three entries. If there are two or fewer entries, there will be no award presented in that category. MM+M will refund all entry fees if a category is not judged.
As in years past, the MM+M Awards are open to agencies and their clients, production companies, studios, research firms and any other organization that produces or publishes medical marketing materials or content. Eligibility is limited to work created for North America, though international work will be considered if it includes a North American component and that component is submitted as part of the entry.
This is your year to shine! Don't miss your opportunity - enter today!
WHY IT'S IMPORTANT TO ENTER THE MM+M AWARDS
- Motivate your team -
- Prove that you are the best in the industry -
- Win new business and impress your clients -
- Recruit shining new talent and retain your hidden gems -
- Showcase your work in front of top healthcare professionals -
- Get recognized for your outstanding work through exposure MM+M gives your projects -
OUR WINNERS MATTER
Winning an MM+M Award doesn't end when the day is over! Past winners are invited back as judges, giving them further insight into the Awards. Winners have also gone on to be featured in awards marketing, making sure everyone knows of our esteemed winners. Outside of the Awards, winners have also been selected to speak at several of our MM+M events and have been featured in both online and print as examples of best practices. We will publicize you to the MM+M world both online and offline, showcasing your organization and outstanding work as the best in the sector.
KEY INFORMATION
KEY DATES
Standard Nomination Deadline:
April 12, 2024
Extended Nomination Deadline:
April 19, 2024
Final Nomination Deadline:
April 26, 2024
Finalists Announced:
July 2024
Live Event Date:
October 10, 2024
KEY FEES
Standard Nomination Fee:
$495.00
Extended Nomination Fee:
$795.00
Final Nomination Fee:
$795.00
OUR WINNERS MATTER
Winning an MM+M Award doesn't end when the day is over!
Past winners are invited back as judges, giving them further insight into the Awards. Winners have also gone on to be featured in awards marketing, making sure everyone knows of our esteemed winners. Outside of the Awards, winners have also been selected to speak at several of our MM+M events and have been featured in both online and print as examples of best practices. We will publicize you to the MM+M world both online and offline, showcasing your organization and outstanding work as the best in the sector.
2024 JURY CHAIR
Eduardo Molina, Vice President of Marketing and Strategy at bluebird bio
Eduardo brings extensive US and global pharmaceutical marketing, including launch experience through a wide variety of strategic and operational commercial roles at large Pharma and biotech companies.
Eduardo is Vice President of Marketing and Strategy at bluebird bio, leading a team in charge for the launch of gene therapies across multiple disease areas. Before bluebird bio, Eduardo was Head of US marketing for Reblozyl at Acceleron Pharma (Acquired by Merck), where he led the marketing strategy and execution for the company’s first product launch in hematology/oncology, and led an extensive cross functional team and worked closely with alliance partners Celgene/BMS to bring to market what today is a +$1Billion product. Prior to Acceleron, he worked at Abbvie for almost 4 years as Director of Global Commercial Development, leading teams responsible for developing the global strategy for the company’s first in-house hematology product (Venclexta), laying the foundation for a blockbuster brand. Before Abbvie, Eduardo spent almost 7 years at Novartis Oncology, where he held a variety of US and global roles of increasing responsibility and was part of multiple strategic hematology launches.
Eduardo lives in Boston and loves traveling to get acquainted with new cultures (while exploring all types of cuisines!) and to spend as much time with his family, and friends. Eduardo enjoys sports, including a love for soccer, reason why he has attended soccer games in 7 different countries (and counting!) and has been to 2 World Cups. He is also an avid amateur cyclist and is usually training for long endurance events that might seem crazy and painful for some (like 200 mile one day races!) but an exciting challenge for him.
THANK YOU TO OUR Sponsors
CONTACT US
Copyright © 2024 Haymarket Media, Inc. All Rights Reserved - Haymarket Media's Privacy Policy and Terms & Conditions.